SRRK

Scholar Rock Holding Corp

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE · CIK 0001727196
$44.18 -1.14% $5.3B
Insider Selling Cluster (4 insiders)High Impact Filing (7/10)25 New Institutional Positions8 Institutional Exits
Vol
Market Cap$5.3B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (96%)
Inst. Holders50 funds
Inst. Value$3.5B
Inst. Activity25 buys / 8 sells
Insider Activity0B / 5S
Insider Net $-$3.5M
SEC Reports5
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001727196·Prev Close $44.69

Recent Activity

Sep 30, 2026 fda_pdufa
PDUFA: SRRK — apitegromab in spinal muscular atrophy (SMA) — 2026-09-30
FDA target action date 2026-09-30 for SRRK (Scholar Rock Holding Corp). Drug: apitegromab. Indicatio
Jun 11, 2026 SEC
A bearish institutional cluster formed in SRRK during Q3 2025, with 6 sellers (including Norges Bank, Citadel, and RenTe
INST-CLUSTER — Impact 6/10
Jun 4, 2026 Insider
AKKARAJU SRINIVAS was granted 6,839 shares
Director
Jun 4, 2026 Insider
Gilman Michael was granted 4,310 shares
Director
Jun 4, 2026 Insider
AKKARAJU SRINIVAS was granted 4,310 shares
Director
May 7, 2026 SEC
Scholar Rock reported Q1 2026 net loss of $0.83/share (vs consensus $0.78 miss), with no revenue. The key positive is FD
8-K — Impact 6/10
Apr 24, 2026 SEC
Four senior executives at Scholar Rock, including the CEO, CFO, and other C-suite leaders, sold shares worth $3.15 milli
CLUSTER — Impact 7/10
Inst.
JANUS HENDERSON GROUP PLC — ADD
2,236,837 shares ($109.9M)

Price Targets

$59.31 +34.3% upside Strong Buy
Current $44.18 Low $48.00 Median $58.00 High $70.00 16 analysts
$48.00 $70.00

Analyst Ratings

Strong Buy96% buy · 24 analysts
9Strong Buy
14Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 8, 2026 Barclays MAINTAIN Overweight → Overweight
May 8, 2026 HC Wainwright & Co. MAINTAIN Buy → Buy
Apr 21, 2026 Canaccord Genuity INITIATE Buy
Apr 1, 2026 Wedbush MAINTAIN Outperform → Outperform
Mar 16, 2026 JP Morgan MAINTAIN Overweight → Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.84 $-0.94 — $-0.77 14% YoY 11
Next Q $-0.86 $-0.99 — $-0.74 4% YoY 14
Current FY $-3.07 $-3.62 — $-2.34 7% YoY 11
Next FY $-2.55 $-3.31 — $-1.56 20% YoY 16

Latest Reports

BEARISH INST-CLUSTER 6/10
A bearish institutional cluster formed in SRRK during Q3 2025, with 6 sellers (including Norges Bank, Citadel, and RenTe
Jun 11, 2026
MIXED 8-K 6/10
Scholar Rock reported Q1 2026 net loss of $0.83/share (vs consensus $0.78 miss), with no revenue. The key positive is FD
May 7, 2026

Top Institutional Holders

FundValueMove
NOMURA ASSET MANAGEMENT CO——
FMR LLC$847.7M—
BlackRock, Inc.$367.2M—
WELLINGTON MANAGEMENT GROUP LLP$330.2MADD
STATE STREET CORP$198.2M—

Recent Insider Trades

DateInsiderTypeValue
Jun 4, 2026AKKARAJU SRINIVASA$0.00
Jun 4, 2026Gilman MichaelA$0.00
Jun 4, 2026AKKARAJU SRINIVASA$0.00
Jun 4, 2026Peng KatieA$0.00
Jun 4, 2026Peng KatieA$0.00
50 institutional holders with $3.5B total value (71,060,394 shares) as of 2026-Q1. Top holders: NOMURA, FMR, BlackRock,. Net buying activity: 25 institutions added/increased vs 8 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1NOMURA ASSET MANAGEMENT CO LTD—$0.000.0%—
2FMR LLC17,243,152$847.7M24.3%—
3BlackRock, Inc.7,469,293$367.2M10.5%—
4WELLINGTON MANAGEMENT GROUP LLP6,717,655$330.2M9.5%ADD +26.7%
5STATE STREET CORP4,031,317$198.2M5.7%—
6VANGUARD CAPITAL MANAGEMENT LLC3,891,347$191.3M5.5%—
7JENNISON ASSOCIATES LLC3,340,492$164.2M4.7%ADD +74.0%
8JANUS HENDERSON GROUP PLC2,236,837$109.9M3.1%ADD +26.1%
9Hood River Capital Management LLC2,049,679$100.8M2.9%—
10Polar Capital Holdings Plc1,983,628$97.5M2.8%ADD +50.0%
11DRIEHAUS CAPITAL MANAGEMENT LLC1,920,233$94.4M2.7%—
12Holocene Advisors, LP1,890,927$93.0M2.7%ADD +36.3%
13Woodline Partners LP1,500,470$73.8M2.1%ADD +39.0%
14GOLDMAN SACHS GROUP INC1,398,983$68.8M2.0%—
15BANK OF AMERICA CORP /DE/1,336,632$65.7M1.9%ADD +27.2%
16Capital World Investors1,128,752$55.5M1.6%—
17MARSHALL WACE, LLP1,060,275$52.1M1.5%DOUBLED +188.1%
18BNP Paribas Asset Management Holding S.A.981,915$48.3M1.4%—
19CITADEL ADVISORS LLC900,799$44.3M1.3%—
20Pictet Asset Management Holding SA875,084$43.0M1.2%TRIM -26.8%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
JANUS HENDERSON GROUP PLCADD1,774,1682,236,837+26.1%$109.9M2026-Q1
Polar Capital Holdings PlcADD1,322,0111,983,628+50.0%$97.5M2026-Q1
Holocene Advisors, LPADD1,387,1201,890,927+36.3%$93.0M2026-Q1
BANK OF AMERICA CORP /DE/ADD1,050,5061,336,632+27.2%$65.7M2026-Q1
MARSHALL WACE, LLPDOUBLED368,0371,060,275+188.1%$52.1M2026-Q1
Pictet Asset Management Holding SATRIM1,195,967875,084-26.8%$43.0M2026-Q1
VOYA INVESTMENT MANAGEMENT LLCADD514,224725,409+41.1%$35.7M2026-Q1
ADAGE CAPITAL PARTNERS GP, L.L.C.NEW—700,000—$34.4M2026-Q1
Clearbridge Investments, LLCDOUBLED295,475691,418+134.0%$34.0M2026-Q1
MORGAN STANLEYTRIM372,731219,027-41.2%$10.8M2026-Q1
BALYASNY ASSET MANAGEMENT L.P.DOUBLED16,647149,714+799.3%$7.4M2026-Q1
Invesco Ltd.ADD82,462119,597+45.0%$5.9M2026-Q1
Trexquant Investment LPADD48,92776,748+56.9%$3.8M2026-Q1
ExodusPoint Capital Management, LPTRIM106,22867,068-36.9%$3.3M2026-Q1
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.ADD45,79861,906+35.2%$3.0M2026-Q1
POLEN CAPITAL MANAGEMENT LLCDOUBLED21,76251,951+138.7%$2.6M2026-Q1
SCHRODER INVESTMENT MANAGEMENT GROUPADD32,82749,942+52.1%$2.2M2026-Q1
TUDOR INVESTMENT CORP ET ALTRIM55,11730,208-45.2%$1.5M2026-Q1
FRANKLIN RESOURCES INCTRIM41,77226,882-35.6%$1.3M2026-Q1
DnB Asset Management ASTRIM35,05921,958-37.4%$1.1M2026-Q1
ENVESTNET ASSET MANAGEMENT INCADD12,48019,481+56.1%$957.7K2026-Q1
Russell Investments Group, Ltd.ADD7,76013,740+77.1%$675.5K2026-Q1
PRUDENTIAL FINANCIAL INCDOUBLED5,03013,615+170.7%$669.3K2026-Q1
Vanguard Personalized Indexing Management, LLCADD5,3418,617+61.3%$423.6K2026-Q1
M&T BANK CORPDOUBLED3,6848,264+124.3%$406.3K2026-Q1
16 unique insiders with 30 transactions. Net insider value: -$3.5M ($0.00 bought, $3.5M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 4, 2026AKKARAJU SRINIVASDirectorAWARD6,839——
Jun 4, 2026Gilman MichaelDirectorAWARD4,310——
Jun 4, 2026AKKARAJU SRINIVASDirectorAWARD4,310——
Jun 4, 2026Peng KatieDirectorAWARD6,839——
Jun 4, 2026Peng KatieDirectorAWARD4,310——
Jun 4, 2026Gilman MichaelDirectorAWARD6,839——
Jun 4, 2026Burow KristinaDirectorAWARD6,839——
Jun 4, 2026Burow KristinaDirectorAWARD4,310——
Jun 4, 2026Brudnick RichardDirectorAWARD6,839——
Jun 4, 2026Brudnick RichardDirectorAWARD4,310——
Jun 4, 2026Reed JoshuaDirectorAWARD6,839——
Jun 4, 2026Reed JoshuaDirectorAWARD4,310——
Jun 4, 2026FLIER JEFFREY S.DirectorAWARD4,310——
Jun 4, 2026FLIER JEFFREY S.DirectorAWARD6,839——
Apr 23, 2026Burow KristinaDirectorEXERCISE7,800$26.78$208.9K
Apr 16, 2026Hallal DavidChief Executive OfficerSELL30,615$49.57$1.5M
Apr 16, 2026Sinha VikasChief Financial OfficerSELL10,410$49.57$516.1K
Apr 16, 2026Vaishnaw AkshayPresident of R&DSELL12,246$49.57$607.1K
Apr 16, 2026Woods KeithChief Operating OfficerSELL10,220$49.57$506.7K
Feb 23, 2026Qatanani MoCHIEF SCIENTIFIC OFFICERSELL7,427$46.94$348.6K
Feb 9, 2026Sinha VikasChief Financial OfficerAWARD47,021——
Feb 9, 2026Marantz Jing L.Chief Medical OfficerAWARD34,482——
Feb 9, 2026Ho JunlinGeneral CounselAWARD36,572——
Feb 9, 2026Parlavecchio CarynChief Human Resources OfficerAWARD29,258——
Feb 9, 2026Qatanani MoChief Scientific OfficerAWARD29,258——
Feb 9, 2026Vaishnaw AkshayPresident of R&DAWARD47,021——
Feb 9, 2026Woods KeithChief Operating OfficerAWARD47,021——
Feb 9, 2026Hallal DavidChief Executive OfficerAWARD128,004——
Dec 11, 2025Invus Global Management, LLC10%+ OwnerEXERCISE1,575,008$7.35$11.6M
Dec 11, 2025Invus Global Management, LLC10%+ OwnerEXERCISE1,575,008——
5 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 2 mixed, 0 neutral. Avg impact: 6.2/10.
BEARISH INST-CLUSTER 6/10
A bearish institutional cluster formed in SRRK during Q3 2025, with 6 sellers (including Norges Bank
Jun 11, 2026
MIXED 8-K 6/10
Scholar Rock reported Q1 2026 net loss of $0.83/share (vs consensus $0.78 miss), with no revenue. Th
May 7, 2026
BEARISH CLUSTER 7/10
Four senior executives at Scholar Rock, including the CEO, CFO, and other C-suite leaders, sold shar
Apr 24, 2026
BEARISH CLUSTER 6/10
The CEO and CFO of Scholar Rock sold a combined $2.03 million in shares through open-market transact
Apr 20, 2026
MIXED INST-CLUSTER 6/10
Three major institutions, including Citadel which doubled its position, increased holdings in Schola
Mar 27, 2026
∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (96% buy). Based on 24 analysts: 9 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$59.31 mean target +34.3% upside Strong Buy (1.17)
$48.00 Low $70.00 High
MetricValue
Current Price$44.18
Target Low$48.00
Target Mean$59.31
Target Median$58.00
Target High$70.00
# Analysts16
RecommendationStrong Buy (1.17)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $-0.84 $-0.94 $-0.77 14.0% +0.0% 3↑ 3↓ $0.0B 0.0% 11
Next Q
2026-09-30
 $-0.86 $-0.99 $-0.74 4.4% +0.0% 4↑ 6↓ $0.0B 0.0% 14
Current FY
2026-12-31
 $-3.07 $-3.62 $-2.34 6.7% +0.0% 3↑ 4↓ $0.0B 0.0% 11
Next FY
2027-12-31
 $-2.55 $-3.31 $-1.56 19.7% +0.0% 2↑ 9↓ $0.1B 2195.3% 16

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.843
7d ago$-0.843
30d ago$-0.843
60d ago$-0.843+0.000
90d ago$-0.871+0.028
10 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 3 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 8, 2026 Barclays MAINTAIN Overweight Overweight
May 8, 2026 HC Wainwright & Co. MAINTAIN Buy Buy
Apr 21, 2026 Canaccord Genuity INITIATE — Buy
Apr 1, 2026 Wedbush MAINTAIN Outperform Outperform
Mar 16, 2026 JP Morgan MAINTAIN Overweight Overweight
Mar 4, 2026 Citigroup MAINTAIN Buy Buy
Mar 4, 2026 BMO Capital MAINTAIN Outperform Outperform
Mar 4, 2026 Truist Securities MAINTAIN Buy Buy
Mar 4, 2026 Barclays MAINTAIN Overweight Overweight
Mar 4, 2026 Piper Sandler MAINTAIN Overweight Overweight
Mar 3, 2026 HC Wainwright & Co. REITERATE Buy Buy
Jan 26, 2026 HC Wainwright & Co. MAINTAIN Buy Buy
Jan 9, 2026 Citigroup INITIATE — Buy
Jan 7, 2026 UBS INITIATE — Buy
Dec 17, 2025 Barclays MAINTAIN Overweight Overweight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202691410096%
May 1, 202691310096%
Apr 1, 202691210095%
Mar 1, 202691210095%
Feb 1, 202691210095%
Jan 1, 202681110095%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Sep 30, 2026
fda_pdufa
PDUFA: SRRK — apitegromab in spinal muscular atrophy (SMA) — 2026-09-30
FDA target action date 2026-09-30 for SRRK (Scholar Rock Holding Corp). Drug: apitegromab. Indication: spinal muscular atrophy (SMA). PDUFA target act
Jun 10, 2026
short_volume
Short Volume: SRRK — 60.2% short (0.4M / 0.7M)
Short: 394,124 | Exempt: 300 | TRF Vol: 654,597 | Short Ratio: 60.2% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: SRRK — 56.2% short (0.7M / 1.3M)
Short: 733,671 | Exempt: 186,157 | TRF Vol: 1,304,916 | Short Ratio: 56.2% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings_calendar
SRRK Q1 2026 Earnings Scheduled — 2026-05-07
Mar 26, 2026
short_volume
Short Volume: SRRK — 78.9% short (0.8M / 1.0M)
Short: 825,153 | Exempt: 0 | TRF Vol: 1,045,659 | Short Ratio: 78.9% | Off-exchange volume (dark pool + OTC)
Mar 25, 2026
short_volume
Short Volume: SRRK — 57.0% short (0.5M / 0.8M)
Short: 477,484 | Exempt: 903 | TRF Vol: 837,529 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)
Mar 24, 2026
short_volume
Short Volume: SRRK — 82.6% short (1.1M / 1.4M)
Short: 1,121,713 | Exempt: 274 | TRF Vol: 1,357,199 | Short Ratio: 82.6% | Off-exchange volume (dark pool + OTC)
Mar 3, 2026
earnings_calendar
SRRK Q4 2025 Earnings After Market Close — 2026-03-03
Mar 3, 2026
short_interest
FTD: SRRK — 20,081 shares ($0.9M) failed to deliver
Settlement: 20260303, Price: $43.48, FTD Value: $873,121.88, SCHOLAR ROCK HLDG CORP
Feb 6, 2026
short_interest
FTD: SRRK — 14,904 shares ($0.7M) failed to deliver
Settlement: 20260206, Price: $44.45, FTD Value: $662,482.8, SCHOLAR ROCK HLDG CORP